Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 713,000 | 616,000 | 619,000 | 1,353,000 | 1,807,000 |
| Receivables | 770,000 | 951,000 | 896,000 | 792,000 | 610,000 |
| Inventories | 1,463,000 | 1,438,000 | 1,368,000 | 1,391,000 | 1,352,000 |
| TOTAL | $3,017,000 | $3,080,000 | $2,937,000 | $3,597,000 | $3,835,000 |
| Non-Current Assets | |||||
| PPE Net | 3,188,000 | 3,173,000 | 3,157,000 | 3,209,000 | 3,216,000 |
| Investments And Advances | 152,000 | 190,000 | 169,000 | 165,000 | 158,000 |
| Intangibles | 49,000 | 49,000 | 105,000 | 105,000 | 105,000 |
| Other Non-Current Assets | 1,103,000 | 971,000 | 881,000 | 902,000 | 937,000 |
| TOTAL | $4,492,000 | $4,383,000 | $4,312,000 | $4,381,000 | $4,416,000 |
| Total Assets | $7,509,000 | $7,463,000 | $7,249,000 | $7,978,000 | $8,251,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54,000 | 53,000 | 37,000 | 41,000 | 51,000 |
| Accounts payable and accrued liabilities | 1,156,000 | 1,069,000 | 938,000 | 963,000 | 1,159,000 |
| Other current liabilities | 214,000 | 208,000 | 200,000 | 208,000 | 218,000 |
| TOTAL | $1,820,000 | $1,777,000 | $1,557,000 | $2,231,000 | $2,486,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,059,000 | 3,988,000 | 3,951,000 | 3,968,000 | 3,987,000 |
| Other Non-Current Liabilities | 1,023,000 | 998,000 | 975,000 | 981,000 | 995,000 |
| TOTAL | $5,117,000 | $5,027,000 | $4,967,000 | $4,993,000 | $5,026,000 |
| Total Liabilities | $6,937,000 | $6,804,000 | $6,524,000 | $7,224,000 | $7,512,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,441 | 149,411 | 149,270 | 148,895 | 148,802 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 1,685,000 | 1,763,000 | 1,828,000 | 1,797,000 | 1,782,000 |
| Other shareholders' equity | -366,000 | -351,000 | -345,000 | -272,000 | -272,000 |
| TOTAL | $572,000 | $659,000 | $725,000 | $754,000 | $739,000 |
| Total Liabilities And Equity | $7,509,000 | $7,463,000 | $7,249,000 | $7,978,000 | $8,251,000 |